24 June 2014 - Deborah Wilkes
Archived
Abbott is set to expand its presence in Russia by acquiring local pharmaceutical company Veropharm in a deal worth up to US$495 million plus the assumption of net debt of US$136 million.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.